Intellia Therapeutics (NASDAQ: NTLA)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Intellia Therapeutics (NASDAQ: NTLA) through any online brokerage.
The latest price target for Intellia Therapeutics (NASDAQ: NTLA) was reported by BMO Capital on Friday, June 17, 2022. The analyst firm set a price target for 54.00 expecting NTLA to fall to within 12 months (a possible -0.02% downside). 25 analyst firms have reported ratings in the last year.
The stock price for Intellia Therapeutics (NASDAQ: NTLA) is $54.01 last updated July 1, 2022, 8:00 PM UTC.
There are no upcoming dividends for Intellia Therapeutics.
Intellia Therapeutics’s Q2 earnings are confirmed for Thursday, August 4, 2022.
There is no upcoming split for Intellia Therapeutics.
Intellia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.